background
protocol
network
laboratori
facilit
develop
rapid
diagnosi
sar
coronaviru
cov
use
revers
transcript
rt
pcr
assay
howev
sever
report
shown
convent
realtim
pcr
assay
specif
sar
cov
lack
sensit
depend
assay
specimen
time
cours
diseas
object
evalu
automat
nucleic
acid
extract
system
two
standard
realtim
pcr
assay
rapid
diagnosi
sar
cov
outbreak
postepidem
period
hong
kong
studi
design
specimen
clinic
suspect
sar
patient
collect
outbreak
postepidem
period
test
automat
nucleic
acid
extract
system
follow
first
gener
convent
rtpcr
two
standard
realtim
pcr
assay
artu
gmbh
germani
roch
diagnost
germani
pair
serum
sampl
assay
increas
titer
sar
cov
result
sar
epidem
artu
roch
pcr
assay
exhibit
sensit
respiratori
specimen
n
stool
n
urin
n
specif
exhibit
pcr
assay
except
artu
attain
specif
stool
postepidem
period
sar
cov
identifi
among
respiratori
specimen
pcr
assay
inhibitor
pcr
assay
detect
averag
rate
among
clinic
specimen
conclus
studi
highlight
high
throughput
perform
automat
rna
extract
coordin
standard
realtim
pcr
assay
suitabl
largescal
routin
diagnosi
case
futur
sar
epidem
sar
cov
detect
among
specimen
collect
postepidem
period
posit
predict
valu
realtim
pcr
assay
detect
sar
cov
low
epidem
requir
evalu
sever
acut
respiratori
syndrom
sar
first
pandem
infecti
diseas
new
millennium
caus
novel
coronaviru
sar
cov
pathogen
swept
across
almost
contin
globe
current
involv
countri
region
includ
mainland
china
hong
kong
taiwan
north
america
europ
drosten
et
al
lee
et
al
peiri
et
al
tsang
et
al
hong
kong
result
reduct
popul
contact
rate
improv
hospit
infect
control
epidem
shown
declin
riley
et
al
world
health
organ
estim
case
sar
death
end
transmiss
cycl
avail
url
control
spread
diseas
reli
rapid
diagnosi
appropri
clinic
manag
earli
reliabl
detect
sar
cov
clinic
specimen
determin
patient
present
fever
immedi
isol
manag
accord
strict
procedur
infect
control
protocol
network
laboratori
avail
url
http
wwwwhointcsrsarsprimersen
facilit
develop
rapid
diagnosi
sar
cov
use
revers
transcript
rt
pcr
assay
howev
sever
report
shown
convent
realtim
pcr
assay
specif
sar
cov
lack
sensit
depend
assay
specimen
time
cours
diseas
peiri
et
al
poon
et
al
yam
et
al
studi
evalu
automat
nucleic
acid
extract
system
coordin
two
commerci
realtim
pcr
assay
use
sar
outbreak
postepidem
period
hong
kong
april
may
total
specimen
nasopharyng
aspir
throat
swab
urin
stool
collect
patient
present
clinic
suspect
sar
three
acut
region
hospit
hong
kong
patient
pair
acuteand
convalescentphas
serum
sampl
least
one
respiratori
specimen
collect
studi
respiratori
specimen
collect
day
admiss
wherea
urin
stool
specimen
collect
day
acutephas
sera
collect
first
week
ill
convalescentphas
sera
collect
day
onset
clinic
symptom
respiratori
specimen
assess
rapid
direct
immunofluoresc
antigen
detect
influenza
viru
type
b
parainfluenza
viru
type
respiratori
syncyti
viru
rsv
adenoviru
chan
et
al
chan
et
al
pair
serum
sampl
assay
increas
titer
sar
cov
describ
previous
chan
et
al
yam
et
al
nine
nasopharyng
aspir
patient
suffer
unrel
diseas
collect
control
clinic
isol
sar
cov
two
human
coronavirus
use
posit
neg
control
subsequ
pcr
assay
last
report
case
confirm
sar
earli
june
anoth
respiratori
specimen
nasopharyng
aspir
throat
swab
also
collect
clinic
suspect
sar
patient
august
septemb
respiratori
specimen
suspend
viral
transport
medium
urin
transport
steril
contain
stool
mix
viral
transport
medium
dilut
centrifug
g
min
supernat
collect
viral
rna
coronaviru
extract
qiagen
robot
system
total
viral
nucleic
acid
qiagen
hilden
germani
initi
process
specimen
perform
biohazard
contain
accord
manufactur
instruct
qiaamp
viru
biorobot
kit
cat
hilden
germani
sampl
volum
l
mix
l
al
buffer
l
proteas
solut
mixtur
incub
c
min
transfer
rack
robot
system
contain
tube
sampl
nucleic
acid
precipit
initi
addit
l
absolut
ethanol
l
buffer
follow
transfer
qiaamp
well
vacuum
manifold
rna
extract
wash
l
buffer
twice
l
buffer
final
volum
l
total
nucleic
acid
elut
addit
l
ave
elut
buffer
sequenti
step
nucleic
acid
precipit
wash
elut
oper
automat
run
nucleic
acid
extract
sampl
requir
h
first
gener
rtpcr
whohku
protocol
perform
use
singl
rt
step
cdna
synthesi
follow
subsequ
pcr
amplif
specif
sens
primer
tacacacctcagcgttg
antisens
primer
cacgaacgtgacgaat
yam
et
al
revers
transcript
carri
random
primer
superscript
ii
rt
invitrogen
usa
kit
total
volum
l
reaction
mix
contain
mm
dtt
dntp
g
random
primer
rt
buffer
u
rt
enzym
well
l
extract
rna
mixtur
incub
c
min
c
min
final
c
min
two
microlitr
rt
product
transfer
pcr
reaction
volum
l
contain
reaction
buffer
dntp
mm
mgso
nm
primer
u
amplitaq
gold
enzym
reaction
mix
denatur
c
min
follow
cycl
c
c
c
final
extens
step
set
c
min
amplifi
product
electrophores
agaros
gel
tri
borat
buffer
target
band
bp
visual
stain
ethidium
bromid
clinic
isol
sar
cov
two
human
coronavirus
use
posit
neg
control
realtim
pcr
perform
use
two
commerci
kit
realart
hpacoronaviru
lc
rt
pcr
kit
artu
gmbh
hamburg
germani
lightcycl
sarscov
quantif
kit
roch
diagnost
germani
assay
readytous
system
detect
sar
cov
rna
use
lightcycl
realtim
pcr
system
roch
diagnost
germani
posit
neg
control
use
convent
rtpcr
also
includ
determin
viral
load
intern
sar
cov
standard
suppli
assay
kit
sampl
intern
control
incorpor
reaction
mix
determin
pcr
inhibit
artu
assay
specif
amplifi
region
sar
cov
genom
primer
probe
sequenc
describ
previous
drosten
et
al
realtim
quantit
amplif
sar
cov
rna
perform
accord
instruct
manufactur
total
l
rna
extract
transfer
reaction
tube
contain
l
pcr
reagent
rt
perform
c
min
amplif
perform
cycl
c
cycl
c
c
c
final
cool
step
perform
c
roch
assay
specif
amplifi
target
sequenc
replicas
gene
sar
cov
select
region
show
signific
sequenc
homolog
coronavirus
human
group
coronavirus
nonsar
covrel
virus
specif
probe
emit
fluoresc
light
hybrid
target
sequenc
realtim
quantit
amplif
sar
cov
rna
perform
accord
instruct
manufactur
total
l
rna
extract
transfer
reaction
tube
contain
l
pcr
reagent
rt
perform
c
min
amplif
perform
cycl
c
cycl
c
c
c
final
cool
step
perform
c
coronaviru
immunoglobulin
g
serolog
test
perform
indirect
immunofluoresc
batch
sar
covinfect
vero
cell
smear
prepar
use
clinic
isol
sar
cov
fix
icecold
aceton
min
cell
adjust
sar
cov
infect
judg
immunofluoresc
stain
control
posit
human
convalescentphas
serum
fix
smear
store
c
use
serum
sampl
screen
dilut
infect
uninfect
control
cell
min
incub
cell
wash
twice
phosphatebuff
salin
pb
min
goat
antihuman
fluorescein
isothiocyan
conjug
inova
diagnost
inc
san
diego
ca
ad
cell
incub
min
c
cell
wash
describ
examin
immunofluoresc
microscop
serum
sampl
posit
screen
dilut
titrat
serial
twofold
dilut
parallel
respect
acutephas
serum
specimen
patient
posit
control
serum
test
batch
cell
laboratori
diagnosi
respiratori
viral
pathogen
direct
immunofluoresc
antigen
dfa
test
carri
nasopharyng
aspir
specimen
describ
previous
chan
et
al
sampl
transfer
viru
transport
medium
centrifug
cell
pellet
resuspend
phosphatebuff
salin
wash
repeat
cycl
centrifug
free
visibl
mucu
cell
pellet
spot
onto
well
teflonco
slide
air
dri
fix
icecold
aceton
min
smear
stain
panel
imagen
antibodi
specif
influenza
viru
type
b
parainfluenza
viru
type
adenoviru
rsv
dako
glostrup
denmark
slide
examin
magnif
epifluoresc
illumin
use
fluorescein
isothiocyan
fitc
filter
fluoresc
microscop
specimen
columnar
epitheli
cell
nasopharyng
aspir
smear
neg
immunofluoresc
specimen
consid
insuffici
respiratori
epitheli
cell
specimen
report
indetermin
among
specimen
patient
clinic
suspect
sar
epidem
period
tabl
collect
patient
confirm
sar
cov
infect
basi
seroconvers
none
common
viral
pathogen
includ
influenza
viru
type
b
parainfluenza
viru
type
rsv
adenoviru
detect
among
respiratori
specimen
use
seroconvers
gold
standard
sar
diagnosi
first
gener
rtpcr
assay
whohku
exhibit
sensit
respiratori
specimen
stool
urin
specif
specimen
sensit
artu
roch
realtim
pcr
assay
found
respiratori
specimen
stool
urin
specif
exhibit
realtim
pcr
assay
except
artu
attain
specif
stool
realtim
pcr
assay
viral
rna
detect
clinic
sampl
rang
copi
artu
copi
roch
assay
fig
high
concord
result
exhibit
realtim
pcr
assay
specimen
artu
detect
sar
cov
rna
two
specimen
sarsconfirm
patient
copi
wherea
roch
pcr
assay
neg
two
specimen
anoth
stool
specimen
artu
roch
detect
sar
cov
rna
copi
howev
patient
subsequ
confirm
sar
neg
seroconvers
clinic
present
except
fals
posit
result
exhibit
artu
pcr
assay
none
seroneg
patient
sampl
human
coronaviru
isol
gave
posit
pcr
result
last
report
case
confirm
sar
earli
june
respiratori
specimen
test
postepidem
period
neg
pcr
assay
base
intern
control
incorpor
reaction
pcr
inhibitor
chan
et
al
sampl
posit
viral
pathogen
includ
flu
adenoviru
rsv
immunofluoresc
chan
et
al
detect
artu
roch
realtim
pcr
assay
serodiagnosi
sar
cov
infect
reliabl
specif
seroconvers
detect
around
day
ill
patient
especi
treat
immunomodul
drug
steroid
may
delay
third
fourth
week
ill
peiri
et
al
poon
et
al
caseexclus
criteria
defin
absenc
antibodi
sar
cov
convalescentphas
serum
sampl
obtain
day
symptom
onset
serv
purpos
rapid
diagnosi
first
gener
inhous
rtpcr
whohku
assay
launch
routin
applic
shown
highli
specif
insensit
yam
et
al
chan
et
al
previou
studi
manual
rna
extract
perform
qiaamp
viral
rna
kit
hilden
germani
use
l
sampl
volum
howev
whohku
assay
exhibit
higher
sensit
studi
compar
previou
find
probabl
account
effici
robot
system
use
larger
initi
sampl
volum
l
viral
rna
extract
standard
pcr
assay
expect
facilit
rapid
diagnosi
sar
cov
routin
practic
studi
commerci
realtim
pcr
assay
significantli
sensit
whohku
assay
latter
miss
mainli
sampl
low
copi
number
sar
cov
rna
artu
pcr
assay
shown
detect
sar
cov
rna
copiesg
lung
tissu
sar
patient
mazzulli
et
al
studi
illustr
sensit
realtim
pcr
assay
specimen
low
viral
load
recent
detect
limit
roch
artu
assay
found
copiesml
copiesml
respect
hourfar
et
al
may
account
slightli
higher
diagnost
sensit
artu
roch
studi
use
lightcycl
system
realtim
pcr
assay
gener
quantit
result
within
h
much
shorter
tradit
pcr
reaction
whohku
protocol
twostep
rtpcr
assay
onestep
realtim
rtpcr
assay
suitabl
routin
diagnost
applic
reduc
risk
cross
contamin
one
fals
posit
result
exhibit
artu
assay
indic
high
specif
pcr
assay
sar
cov
minim
cross
contamin
introduc
robot
system
viral
rna
extract
clinic
specimen
recent
studi
use
sampl
confirm
sar
patient
verifi
higher
sensit
roch
artu
assay
first
gener
test
drosten
et
al
studi
elucid
specif
commerci
realtim
pcr
assay
suitabl
routin
applic
detect
rate
pcr
inhibitor
remain
moder
low
demonstr
coordin
automat
rna
extract
system
realtim
pcr
assay
effici
routin
screen
sar
cov
less
technologist
time
routin
diagnosi
case
presenc
pcr
inhibitor
second
sampl
request
immedi
repeat
pcr
assay
laboratori
one
technologistscientist
perform
rna
extract
realtim
pcr
assay
sampl
work
day
data
shown
convey
anoth
studi
use
store
clinic
sampl
inhous
realtim
pcr
assay
four
time
volum
respiratori
specimen
manual
viral
rna
extract
sensit
assay
compar
two
commerci
pcr
assay
studi
howev
effect
pcr
inhibitor
due
increas
initi
sampl
volum
rna
extract
evalu
previou
studi
shown
earlier
test
one
respiratori
specimen
maxim
sensit
pcr
assay
assess
studi
due
limit
suppli
commerci
kit
yam
et
al
rapid
diagnosi
sar
cov
pcr
assay
use
epidem
postepidem
period
sar
cov
detect
pcr
assay
use
studi
monitor
reemerg
sar
cov
infect
rapid
diagnosi
import
time
therapeut
intervent
also
identif
begin
outbreak
posit
predict
valu
pcr
assay
sporad
case
epidemiolog
link
case
recent
sar
southern
china
requir
investig
avail
url
http
nevertheless
detect
quantif
sar
cov
realtim
pcr
assay
relev
rapid
diagnosi
treatment
plan
avoid
fals
alarm
conting
plan
toward
sar
cov
epidem
initi
posit
laboratori
test
need
valid
second
laboratori
region
repeat
pcr
assay
anoth
target
studi
highlight
high
throughput
perform
automat
rna
extract
standard
realtim
pcr
assay
suitabl
largescal
routin
diagnosi
case
futur
sar
epidem
